Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study (Q48590341)

13 February 2018

title

Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study (English)

1 reference

13 February 2018

0 references

1

1 reference

13 February 2018

Andreas Meyer-Lindenberg

6

1 reference

13 February 2018

author name string

Franziska Rausch

2

1 reference

13 February 2018

Susanne Englisch

3

1 reference

13 February 2018

Sarah Eifler

4

1 reference

13 February 2018

Christine Esslinger

5

1 reference

13 February 2018

Mathias Zink

7

1 reference

13 February 2018

language of work or name

English

0 references

publication date

24 October 2012

1 reference

13 February 2018

Journal of Psychopharmacology

published in

1 reference

13 February 2018

volume

27

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

349-357

1 reference

13 February 2018

How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association

cites work

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Psychiatric comorbidities and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive symptoms and positive, negative, and depressive symptoms in patients with recent-onset schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

The 5-Year Course of Obsessive-Compulsive Symptoms and Obsessive-Compulsive Disorder in First-Episode Schizophrenia and Related Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

A longitudinal study of obsessive-compulsive disorder in individuals at ultra-high risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

International consensus study of antipsychotic dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Management of schizophrenia with obsessive-compulsive features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine: a distinct, poorly understood and under-used molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine: more side effects but still the best antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive symptoms in schizophrenia: prevalence, correlates and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Psychological treatment of obsessive-compulsive disorder: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Interaction between genetic variants ofDLGAP3andSLC1A1Affecting the Risk of Atypical Antipsychotics‐Induced Obsessive–Compulsive Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Effectiveness of aripiprazole in treating obsessive compulsive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0269881112463470

21 January 2018

Identifiers

DOI

10.1177/0269881112463470

1 reference

13 February 2018

1 reference

13 February 2018